# EDGAR Filing Document

**Accession Number:** 0000006281
**File Stem:** 0000006281-26-000052
**Filing Date:** 2026-5
**Character Count:** 91915
**Document Hash:** 6ee79ec36b6d7dc3dfe8ff00fe371d10
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000006281-26-000052.hdr.sgml**: 20260520

**ACCESSION NUMBER**: 0000006281-26-000052

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 63

**CONFORMED PERIOD OF REPORT**: 20260502

**FILED AS OF DATE**: 20260520

**DATE AS OF CHANGE**: 20260520

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ANALOG DEVICES INC
- **CENTRAL INDEX KEY:** 0000006281
- **STANDARD INDUSTRIAL CLASSIFICATION:** SEMICONDUCTORS & RELATED DEVICES [3674]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 042348234
- **STATE OF INCORPORATION:** MA
- **FISCAL YEAR END:** 1101

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-07819
- **FILM NUMBER:** 261001377

**BUSINESS ADDRESS:**
- **STREET 1:** ONE ANALOG WAY
- **CITY:** WILMINGTON
- **STATE:** MA
- **ZIP:** 01887
- **BUSINESS PHONE:** 7813294700

**MAIL ADDRESS:**
- **STREET 1:** ONE ANALOG WAY
- **CITY:** WILMINGTON
- **STATE:** MA
- **ZIP:** 01887

?xml version='1.0' encoding='ASCII'? adi-20260502

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

**Form 10-Q** 

(Mark One)

---

| | |
|:---|:---|
| ☑ | **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934** |

---

**For the quarterly period ended May 2, 2026** 

 **&nbsp;&nbsp;&nbsp;&nbsp;OR**

☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the transition period from<u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u> to <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>**

**Commission File No. 1-7819** 

**Analog Devices, Inc.** 

*(Exact name of registrant as specified in its charter)* 

---

| | | | |
|:---|:---|:---|:---|
| **Massachusetts** | **Massachusetts** | **Massachusetts** | **04-2348234** |
| *(State or other jurisdiction of incorporation or organization)* | *(State or other jurisdiction of incorporation or organization)* | *(State or other jurisdiction of incorporation or organization)* | *(I.R.S. Employer Identification No.)* |
| **One Analog Way,** | **Wilmington,** | **MA** | **01887** |
| *(Address of principal executive offices)* | *(Address of principal executive offices)* | *(Address of principal executive offices)* | *(Zip Code)* |

---

**(781) 935-5565** 

*(Registrant's telephone number, including area code)*

*(Former name, former address and former fiscal year, if changed since last report)*

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| Common Stock $0.16 2/3 par value per share | ADI | Nasdaq Global Select Market |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.&nbsp;&nbsp;&nbsp;&nbsp;Yes ☑&nbsp;&nbsp;&nbsp;&nbsp;No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&nbsp;&nbsp;&nbsp;&nbsp;Yes ☑&nbsp;&nbsp;&nbsp;&nbsp;No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☑ | Accelerated filer | ☐ |
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ |
| | | Emerging growth company | ☐ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ◻

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&nbsp;&nbsp;&nbsp;&nbsp;Yes ☐&nbsp;&nbsp;&nbsp;&nbsp;No ☑

As of May 2, 2026 there were 487,087,040 shares of common stock of the registrant, $0.16 2/3 par value per share, outstanding.

------

**PART I — FINANCIAL INFORMATION**

---

| | |
|:---|:---|
| **ITEM 1.** | **Financial Statements** |

---

**ANALOG DEVICES, INC.**

**CONDENSED CONSOLIDATED STATEMENTS OF INCOME**

**(Unaudited)**

**(in thousands, except per share amounts)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
| | **May 2, 2026** | **May 3, 2025** | **May 2, 2026** | **May 3, 2025** |
| Revenue | $3623465 | $2640068 | $6783728 | $5063242 |
| Cost of sales | 1183667 | 1028458 | 2298955 | 2021329 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gross margin | 2439798 | 1611610 | 4484773 | 3041913 |
| Operating expenses: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Research and development | 509323 | 441837 | 976723 | 844729 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Selling, marketing, general and administrative | 362810 | 302669 | 708063 | 587465 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of intangibles | 187985 | 187415 | 375300 | 374830 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Special charges, net |  | 1745 | 47982 | 65632 |
| Total operating expenses | 1060118 | 933666 | 2108068 | 1872656 |
| Operating income: | 1379680 | 677944 | 2376705 | 1169257 |
| Nonoperating expense (income): |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest expense | 87619 | 74703 | 173963 | 149967 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest income | (28565) | (21725) | (60822) | (45212) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other, net | (4202) | (962) | (7135) | 2998 |
| Total nonoperating expense (income) | 54852 | 52016 | 106006 | 107753 |
| Income before income taxes | 1324828 | 625928 | 2270699 | 1061504 |
| Provision for income taxes | 148478 | 56158 | 263523 | 100418 |
| Net income | $1176350 | $569770 | $2007176 | $961086 |
| Shares used to compute earnings per common share – basic | 487605 | 496173 | 488239 | 496145 |
| Shares used to compute earnings per common share – diluted | 490458 | 498201 | 491057 | 498434 |
| Basic earnings per common share | $2.41 | $1.15 | $4.11 | $1.94 |
| Diluted earnings per common share | $2.40 | $1.14 | $4.09 | $1.93 |

---

See accompanying notes.

------

**ANALOG DEVICES, INC.**

**CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME**

**(Unaudited)**

**(in thousands)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
| | **May 2, 2026** | **May 3, 2025** | **May 2, 2026** | **May 3, 2025** |
| Net income | $1176350 | $569770 | $2007176 | $961086 |
| &nbsp;&nbsp;&nbsp;Foreign currency translation adjustments | 1036 | (753) | 1324 | (912) |
| &nbsp;&nbsp;&nbsp;Change in fair value of derivative instruments designated as cash flow hedges, net | (5033) | 17573 | 620 | 17496 |
| &nbsp;&nbsp;&nbsp;Changes in pension plans, net | 195 | 517 | 395 | 1040 |
| &nbsp;&nbsp;&nbsp;Other comprehensive (loss) income | (3802) | 17337 | 2339 | 17624 |
| Comprehensive income | $1172548 | $587107 | $2009515 | $978710 |

---

See accompanying notes.

------

**ANALOG DEVICES, INC.**

**CONDENSED CONSOLIDATED BALANCE SHEETS** 

**(Unaudited)**

**(in thousands, except share and per share amounts)**

---

| | | |
|:---|:---|:---|
| | **May 2, 2026** | **November 1, 2025** |
| **ASSETS** | | |
| **Current Assets** | | |
| &nbsp;&nbsp;&nbsp;Cash and cash equivalents | $2436916 | $2499406 |
| &nbsp;&nbsp;&nbsp;Short-term investments | 1002392 | 1152915 |
| &nbsp;&nbsp;&nbsp;Accounts receivable | 2051733 | 1436075 |
| &nbsp;&nbsp;&nbsp;Inventories | 1848405 | 1656323 |
| &nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | 470327 | 363342 |
| &nbsp;&nbsp;&nbsp;Total current assets | 7809773 | 7108061 |
| **Non-current Assets** |  |  |
| &nbsp;&nbsp;&nbsp;Net property, plant and equipment | 3292288 | 3315696 |
| &nbsp;&nbsp;&nbsp;Goodwill | 26973180 | 26945180 |
| &nbsp;&nbsp;&nbsp;Intangible assets, net | 7255362 | 8013815 |
| &nbsp;&nbsp;&nbsp;Deferred tax assets | 1729558 | 1867102 |
| &nbsp;&nbsp;&nbsp;Other assets | 888934 | 742858 |
| &nbsp;&nbsp;&nbsp;Total non-current assets | 40139322 | 40884651 |
| **TOTAL ASSETS** | $47949095 | $47992712 |
| **LIABILITIES AND SHAREHOLDERS' EQUITY** |  |  |
| **Current Liabilities** |  |  |
| &nbsp;&nbsp;&nbsp;Accounts payable | $598640 | $543760 |
| &nbsp;&nbsp;&nbsp;Income taxes payable | 325626 | 610370 |
| &nbsp;&nbsp;&nbsp;Debt, current | 899227 |  |
| &nbsp;&nbsp;&nbsp;Commercial paper notes | 550198 | 446639 |
| &nbsp;&nbsp;&nbsp;Accrued liabilities | 2083216 | 1645032 |
| &nbsp;&nbsp;&nbsp;Total current liabilities | 4456907 | 3245801 |
| **Non-current Liabilities** |  |  |
| &nbsp;&nbsp;&nbsp;Long-term debt | 7235424 | 8145066 |
| &nbsp;&nbsp;&nbsp;Deferred income taxes | 1906115 | 2163281 |
| &nbsp;&nbsp;&nbsp;Income taxes payable | 87109 | 100963 |
| &nbsp;&nbsp;&nbsp;Other non-current liabilities | 521507 | 521846 |
| &nbsp;&nbsp;&nbsp;Total non-current liabilities | 9750155 | 10931156 |
| **Shareholders' Equity** |  |  |
| &nbsp;&nbsp;Preferred stock, $1.00 par value, 471,934 shares authorized, none outstanding |  |  |
| &nbsp;&nbsp;Common stock, $0.16 2/3 par value, 1,200,000,000 shares authorized, 487,087,040 shares outstanding (489,654,097 on November 1, 2025) | 81183 | 81611 |
| &nbsp;&nbsp;&nbsp;Capital in excess of par value | 22287095 | 23349185 |
| &nbsp;&nbsp;&nbsp;Retained earnings | 11525998 | 10539541 |
| &nbsp;&nbsp;&nbsp;Accumulated other comprehensive loss | (152243) | (154582) |
| &nbsp;&nbsp;&nbsp;Total shareholders' equity | 33742033 | 33815755 |
| **TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY** | $47949095 | $47992712 |

---

See accompanying notes.

------

**ANALOG DEVICES, INC.**

**CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY**

**(Unaudited)**

**(in thousands)**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended May 2, 2026** | **Three Months Ended May 2, 2026** | **Three Months Ended May 2, 2026** | **Three Months Ended May 2, 2026** | **Three Months Ended May 2, 2026** |
| | **Common Stock** | **Common Stock** | | | |
| | **Shares** | **Amount** | **Capital in**<br>**Excess of**<br>**Par Value** |<br>**Retained**<br>**Earnings** | **Accumulated<br>Other**<br>**Comprehensive**<br>**Loss** |
| **BALANCE, JANUARY 31, 2026** | 488204 | $81369 | $22968224 | $10886107 | $(148441) |
| Net income |  |  |  | 1176350 |  |
| Dividends declared and paid - $1.10 per share |  |  |  | (536459) |  |
| Issuance of stock under stock plans and other | 1202 | 201 | 9665 |  |  |
| Stock-based compensation expense |  |  | 81721 |  |  |
| Other comprehensive loss |  |  |  |  | (3802) |
| Common stock repurchased | (2319) | (387) | (772515) |  |  |
| **BALANCE, MAY 2, 2026** | 487087 | $81183 | $22287095 | $11525998 | $(152243) |
|  | **Six Months Ended May 2, 2026** | **Six Months Ended May 2, 2026** | **Six Months Ended May 2, 2026** | **Six Months Ended May 2, 2026** | **Six Months Ended May 2, 2026** |
|  |  |  | **Capital in** |  | **Accumulated<br>Other** |
|  | **Common Stock** | **Common Stock** | **Excess of** | **Retained** | **Comprehensive** |
|  | **Shares** | **Amount** | **Par Value** | **Earnings** | **Loss** |
| **BALANCE, NOVEMBER 1, 2025** | 489654 | $81611 | $23349185 | $10539541 | $(154582) |
| Net income |  |  |  | 2007176 |  |
| Dividends declared and paid - $2.09 per share |  |  |  | (1020719) |  |
| Issuance of stock under stock plans and other | 1663 | 277 | 59210 |  |  |
| Stock-based compensation expense |  |  | 167396 |  |  |
| Other comprehensive income |  |  |  |  | 2339 |
| Common stock repurchased | (4230) | (705) | (1288696) |  |  |
| **BALANCE, MAY 2, 2026** | 487087 | $81183 | $22287095 | $11525998 | $(152243) |

---

See accompanying notes.

------

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended May 3, 2025** | **Three Months Ended May 3, 2025** | **Three Months Ended May 3, 2025** | **Three Months Ended May 3, 2025** | **Three Months Ended May 3, 2025** |
| | **Common Stock** | **Common Stock** | | | |
| | **Shares** | **Amount** | **Capital in**<br>**Excess of**<br>**Par Value** |<br>**Retained**<br>**Earnings** | **Accumulated<br>Other**<br>**Comprehensive**<br>**Loss** |
| **BALANCE, FEBRUARY 1, 2025** | 495976 | $82664 | $25041250 | $10131590 | $(184969) |
| Net income |  |  |  | 569770 |  |
| Dividends declared and paid - $0.99 per share |  |  |  | (491022) |  |
| Issuance of stock under stock plans and other | 1491 | 249 | 19566 |  |  |
| Stock-based compensation expense |  |  | 72831 |  |  |
| Other comprehensive income |  |  |  |  | 17337 |
| Common stock repurchased | (1219) | (203) | (248443) |  |  |
| **BALANCE, MAY 3, 2025** | 496248 | $82710 | $24885204 | $10210338 | $(167632) |
|  | **Six Months Ended May 3, 2025** | **Six Months Ended May 3, 2025** | **Six Months Ended May 3, 2025** | **Six Months Ended May 3, 2025** | **Six Months Ended May 3, 2025** |
|  |  |  | **Capital in** |  | **Accumulated<br>Other** |
|  | **Common Stock** | **Common Stock** | **Excess of** | **Retained** | **Comprehensive** |
|  | **Shares** | **Amount** | **Par Value** | **Earnings** | **Loss** |
| **BALANCE, NOVEMBER 2, 2024** | 496297 | $82718 | $25082243 | $10196612 | $(185256) |
| Net income |  |  |  | 961086 |  |
| Dividends declared and paid - $1.91 per share |  |  |  | (947360) |  |
| Issuance of stock under stock plans and other | 1902 | 317 | 61245 |  |  |
| Stock-based compensation expense |  |  | 150405 |  |  |
| Other comprehensive income |  |  |  |  | 17624 |
| Common stock repurchased | (1951) | (325) | (408689) |  |  |
| **BALANCE, MAY 3, 2025** | 496248 | $82710 | $24885204 | $10210338 | $(167632) |

---

See accompanying notes.

------

**ANALOG DEVICES, INC.**

**CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS**

**(Unaudited)**

**(in thousands)**

---

| | | |
|:---|:---|:---|
|  | **Six Months Ended** | **Six Months Ended** |
| | **May 2, 2026** | **May 3, 2025** |
| Cash flows from operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income | $2007176 | $961086 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjustments to reconcile net income to net cash provided by operations: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation | 210843 | 198781 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of intangibles | 770593 | 817429 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation expense | 167396 | 150405 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred income taxes | (120930) | (149370) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other | 4727 | 4203 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Changes in operating assets and liabilities | (799249) | (36247) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total adjustments | 233380 | 985201 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by operating activities | 2240556 | 1946287 |
| Cash flows from investing activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Maturities of short-term available-for-sale investments | 147817 | 372778 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Additions to property, plant and equipment, net | (247015) | (239246) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from sale of property, plant and equipment, net |  | 58892 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payments for acquisitions, net of cash acquired | (35875) | (45652) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other | (23882) | (12880) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash (used for) provided by investing activities | (158955) | 133892 |
| Cash flows from financing activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Debt repayments |  | (399998) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from commercial paper notes | 7154789 | 4316340 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payments of commercial paper notes | (7051230) | (4315358) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Repurchase of common stock | (1289401) | (409014) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dividend payments to shareholders | (1020719) | (947360) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from employee stock plans | 59487 | 61562 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other | 2983 | (1458) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash used for financing activities | (2144091) | (1695286) |
| Net (decrease) increase in cash and cash equivalents | (62490) | 384893 |
| Cash and cash equivalents at beginning of period | 2499406 | 1991342 |
| Cash and cash equivalents at end of period | $2436916 | $2376235 |

---

See accompanying notes.

------

**ANALOG DEVICES, INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**FOR THE THREE AND SIX MONTHS ENDED MAY 2, 2026 (UNAUDITED)**

**(all tabular amounts in thousands except per share amounts and percentages)**

**Note 1 – Basis of Presentation**

In the opinion of management, the information furnished in the accompanying condensed consolidated financial statements reflects all normal recurring adjustments that are necessary to fairly state the results for these interim periods and should be read in conjunction with Analog Devices, Inc.'s (the Company) Annual Report on Form 10-K for the fiscal year ended November 1, 2025 (fiscal 2025) and related notes. The results of operations for the interim periods shown in this report are not necessarily indicative of the results that may be expected for the fiscal year ending October 31, 2026 (fiscal 2026) or any future period.

The Company has a 52-53 week fiscal year that ends on the Saturday closest to the last day in October. Certain prior-year amounts have been reclassified to conform to the fiscal 2026 presentation.

**Note 2 – Shareholders' Equity**

As of May 2, 2026, the Company's Board of Directors had authorized the repurchase of an aggregate of $26.7 billion of its common stock under its common stock repurchase program and $8.5 billion remained available for repurchases under the program.

**Note 3 – Accumulated Other Comprehensive (Loss) Income** 

The following table provides the changes in accumulated other comprehensive (loss) income (AOCI) by component and the related tax effects during the first six months of fiscal 2026.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Foreign currency translation adjustment** | **Unrealized holding gains/losses on derivatives** | **Pension plans** | **Total** |
| **November 1, 2025** | $(71700) | $(69777) | $(13105) | $(154582) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive income before reclassifications | 1324 | (6694) |  | (5370) |
| &nbsp;&nbsp;&nbsp;&nbsp;Amounts reclassified out of other comprehensive income |  | 8517 | 395 | 8912 |
| &nbsp;&nbsp;&nbsp;&nbsp;Tax effects |  | (1203) |  | (1203) |
| Other comprehensive income | 1324 | 620 | 395 | 2339 |
| **May 2, 2026** | $(70376) | $(69157) | $(12710) | $(152243) |

---

The amounts reclassified out of AOCI into the Condensed Consolidated Statements of Income and the Condensed Consolidated Statements of Shareholders' Equity with presentation location during each period were as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** | |
|<br>**Comprehensive (Loss) Income Component** | **May 2, 2026** | **May 3, 2025** | **May 2, 2026** | **May 3, 2025** |<br>**Location** |
| Unrealized holding gains/losses on derivatives: | Unrealized holding gains/losses on derivatives: | Unrealized holding gains/losses on derivatives: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Currency forwards | $(552) | $446 | $72 | $(1133) | Cost of sales |
|  | (42) | 118 | 676 | (729) | Research and development |
|  | (513) | 36 | 307 | (2048) | Selling, marketing, general and administrative |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest rate derivatives | 3731 | 3731 | 7462 | 7462 | Interest expense |
|  | 2624 | 4331 | 8517 | 3552 | Total before tax |
|  | (667) | (850) | (1690) | (1008) | Tax |
| Total amounts reclassified out of AOCI, net of tax | $1957 | $3481 | $6827 | $2544 |  |

---

------

**Note 4 – Earnings Per Share**

The following table sets forth the computation of basic and diluted earnings per share:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
| | **May 2, 2026** | **May 3, 2025** | **May 2, 2026** | **May 3, 2025** |
| Net income | $1176350 | $569770 | $2007176 | $961086 |
| Basic shares: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Weighted-average shares outstanding | 487605 | 496173 | 488239 | 496145 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Earnings per common share basic: | $2.41 | $1.15 | $4.11 | $1.94 |
| Diluted shares: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Weighted-average shares outstanding | 487605 | 496173 | 488239 | 496145 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Assumed exercise of common stock equivalents | 2853 | 2028 | 2818 | 2289 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Weighted-average common and common equivalent shares | 490458 | 498201 | 491057 | 498434 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Earnings per common share diluted: | $2.40 | $1.14 | $4.09 | $1.93 |
| Anti-dilutive shares related to: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Outstanding stock-based awards | 21 | 52 | 63 | 121 |

---

**Note 5 – Special Charges, Net**

Liabilities related to special charges, net are included in Accrued liabilities in the Condensed Consolidated Balance Sheets. The activity is detailed below:

---

| | |
|:---|:---|
| **<u>Accrued Special Charges</u>** | **Global Repositioning Actions** |
| **Balance at November 1, 2025** | $**4115** |
| Employee severance costs, net | 29085 |
| Severance payments | (1952) |
| **Balance at January 31, 2026** | $**31248** |
| Severance payments | (17858) |
| **Balance at May 2, 2026** | $**13390** |

---

The Company recorded net special charges of $32.4 million as part of its Global Repositioning Actions in the six months ended May 2, 2026. The Global Repositioning Actions were part of a transformation initiative aimed at aligning the Company's enterprise strategy and organizational design and streamlining its operations to achieve its long-term strategic plan. The special charges include severance costs, in accordance with the Company's ongoing benefit plan or statutory requirements at foreign locations, related to the termination of certain employees in manufacturing, engineering and selling, marketing, general and administrative roles.

During the first quarter of fiscal 2026, the Company entered into a sublease agreement for its leased property in San Jose, California. As a result of the sublease transaction, the Company recorded an impairment charge of $15.6 million in net special charges, which represented the excess carrying value of the associated asset group over its estimated fair value. The Company estimated fair value using cash flows from the estimated net sublease rental income discounted at a market rate.

------

**Note 6 – Industry and Segment Information**

The Company's Chief Executive Officer and Chair has been identified as its Chief Operating Decision Maker (CODM). The following table presents a summary of consolidated net income inclusive of significant segment expenses and other expense information provided to the CODM:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
| | **May 2, 2026** | **May 3, 2025** | **May 2, 2026** | **May 3, 2025** |
| Revenue | $3623465 | $2640068 | $6783728 | $5063242 |
| Less: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Cost of sales, including human capital expenses therein | 1183667 | 1028458 | 2298955 | 2021329 |
| &nbsp;&nbsp;&nbsp;Operating expenses: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Employee compensation costs | 640791 | 531119 | 1243278 | 998715 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of acquired intangible assets | 187985 | 187415 | 375300 | 374830 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Research and development related costs (excluding employee compensation costs) | 150186 | 132443 | 279035 | 263925 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Special charges, net |  | 1745 | 47982 | 65632 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other operating expense (excluding employee compensation costs) (1) | 81156 | 80944 | 162473 | 169554 |
| &nbsp;&nbsp;Nonoperating expense (income)  | 54852 | 52016 | 106006 | 107753 |
| &nbsp;&nbsp;&nbsp;Provision for income taxes | 148478 | 56158 | 263523 | 100418 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income | $1176350 | $569770 | $2007176 | $961086 |

---

_______________________________________

(1)Includes depreciation and amortization expenses, facilities expenses, legal expenses and other discretionary expenses.

*Revenue Trends by End Market*

The following tables summarize revenue by end market. The categorization of revenue by end market is determined using a variety of data points including the technical characteristics of the product, the "sold to" customer information, the "ship to" customer information and the end customer product or application into which the Company's product will be incorporated. The assignment of products to end markets may change over time. When this occurs, the Company reclassifies revenue by end market for prior periods. Such reclassifications typically do not materially change the sizing of, or the underlying trends of results within, each end market.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** |
| | **May 2, 2026** | **May 2, 2026** | **May 2, 2026** | **May 3, 2025** | **May 3, 2025** |
| | **Revenue** | **% of Revenue\*** | **Y/Y%** | **Revenue** | **% of Revenue\*** |
| Industrial | $1799413 | 50% | 56% | $1150315 | 44% |
| Automotive | 871565 | 24% | 2% | 856090 | 32% |
| Communications | 554728 | 15% | 79% | 310604 | 12% |
| Consumer | 397759 | 11% | 23% | 323059 | 12% |
| **Total revenue** | $**3623465** | **100%** | **37%** | $**2640068** | **100%** |
|  | **Six Months Ended** | **Six Months Ended** | **Six Months Ended** | **Six Months Ended** | **Six Months Ended** |
|  | **May 2, 2026** | **May 2, 2026** | **May 2, 2026** | **May 3, 2025** | **May 3, 2025** |
|  | **Revenue** | **% of Revenue\*** | **Y/Y%** | **Revenue** | **% of Revenue\*** |
| Industrial | $3296449 | 49% | 48% | $2220569 | 44% |
| Automotive | 1681709 | 25% | 5% | 1596349 | 32% |
| Communications | 1009911 | 15% | 65% | 610905 | 12% |
| Consumer | 795659 | 12% | 25% | 635419 | 13% |
| **Total revenue** | $**6783728** | **100%** | **34%** | $**5063242** | **100%** |
| \* The sum of the individual percentages may not equal the total due to rounding. | \* The sum of the individual percentages may not equal the total due to rounding. | \* The sum of the individual percentages may not equal the total due to rounding. | \* The sum of the individual percentages may not equal the total due to rounding. | \* The sum of the individual percentages may not equal the total due to rounding. | \* The sum of the individual percentages may not equal the total due to rounding. |

---

------

*Revenue by Sales Channel*

The following tables summarize revenue by sales channel. The Company sells its products globally through a direct sales force, third-party distributors, independent sales representatives and via its website. Distributors are customers that buy products with the intention of reselling them. Direct customers are non-distributor customers and consist primarily of original equipment manufacturers. Other customers include the U.S. government, government prime contractors and certain commercial customers for which revenue is recorded over time.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** |
| | **May 2, 2026** | **May 2, 2026** | **May 3, 2025** | **May 3, 2025** |
| <u>Channel</u> | **Revenue** | **% of Revenue\*** | **Revenue** | **% of Revenue\*** |
| &nbsp;&nbsp;&nbsp;&nbsp;Distributors | $2071312 | 57% | $1480088 | 56% |
| &nbsp;&nbsp;&nbsp;&nbsp;Direct customers | 1520090 | 42% | 1125775 | 43% |
| &nbsp;&nbsp;&nbsp;&nbsp;Other | 32063 | 1% | 34205 | 1% |
| **Total revenue** | $**3623465** | **100%** | $**2640068** | **100%** |
|  | **Six Months Ended** | **Six Months Ended** | **Six Months Ended** | **Six Months Ended** |
|  | **May 2, 2026** | **May 2, 2026** | **May 3, 2025** | **May 3, 2025** |
| <u>Channel</u> | **Revenue** | **% of Revenue\*** | **Revenue** | **% of Revenue\*** |
| &nbsp;&nbsp;&nbsp;&nbsp;Distributors | $3813606 | 56% | $2855552 | 56% |
| &nbsp;&nbsp;&nbsp;&nbsp;Direct customers | 2897220 | 43% | 2145647 | 42% |
| &nbsp;&nbsp;&nbsp;&nbsp;Other | 72902 | 1% | 62043 | 1% |
| **Total revenue** | $**6783728** | **100%** | $**5063242** | **100%** |
| \* The sum of the individual percentages may not equal the total due to rounding. | \* The sum of the individual percentages may not equal the total due to rounding. | \* The sum of the individual percentages may not equal the total due to rounding. | \* The sum of the individual percentages may not equal the total due to rounding. | \* The sum of the individual percentages may not equal the total due to rounding. |

---

------

**Note 7 – Fair Value**

***Assets and Liabilities Recorded at Fair Value on a Recurring Basis***

The tables below, set forth by level, present the Company's financial assets and liabilities, excluding accrued interest components that were accounted for at fair value on a recurring basis as of May 2, 2026 and November 1, 2025. The tables exclude cash on hand and assets and liabilities that are measured at historical cost or any basis other than fair value. As of May 2, 2026 and November 1, 2025, the Company held $1.3 billion and $1.4 billion, respectively, of cash that is excluded from the tables below.

---

| | | | |
|:---|:---|:---|:---|
| | **May 2, 2026** | **May 2, 2026** | **May 2, 2026** |
| | **Fair Value Measurement at**<br>**Reporting Date Using:** | **Fair Value Measurement at**<br>**Reporting Date Using:** | |
| | **Quoted Prices in Active Markets for Identical Assets**<br>**(Level 1)** | **Significant Other Observable Inputs**<br>**(Level 2)** | <br>**Total** |
| **Assets** | | | |
| **Cash equivalents:** | | | |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Available-for-sale: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Government and institutional money market funds | $702844 | $— | $702844 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Corporate obligations (1) |  | 397786 | 397786 |
| **Short-term investments:** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Available-for-sale: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Corporate obligations (1) |  | 507277 | 507277 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Bank obligations (1) |  | 495115 | 495115 |
| **Other assets:** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Forward foreign currency exchange contracts (2) |  | 6500 | 6500 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred compensation plan investments | 117894 |  | 117894 |
| **Total assets measured at fair value** | $820738 | $1406678 | $2227416 |
| **Liabilities** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Forward foreign currency exchange contracts (2) | $— | $10020 | $10020 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest rate derivatives (3) |  | 23882 | 23882 |
| **Total liabilities measured at fair value** | $— | $33902 | $33902 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)The amortized cost of the Company's investments classified as available-for-sale as of May 2, 2026 was $1.4 billion.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)The Company has master netting arrangements by counterparty with respect to derivative contracts. See Note 8, *Derivatives,* in these Notes to Condensed Consolidated Financial Statements for more information related to the Company's master netting arrangements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)The carrying value of the related debt was adjusted by an equal and offsetting amount. The fair value of interest rate derivatives is estimated using a discounted cash flow analysis based on the contractual terms of the derivatives. See Note 8, *Derivatives,* in these Notes to Condensed Consolidated Financial Statements.

------

---

| | | | |
|:---|:---|:---|:---|
| | **November 1, 2025** | **November 1, 2025** | **November 1, 2025** |
| | **Fair Value Measurement at**<br>**Reporting Date Using:** | **Fair Value Measurement at**<br>**Reporting Date Using:** | |
|  | **Quoted Prices in Active Markets for Identical Assets**<br>**(Level 1)** | **Significant Other Observable Inputs**<br>**(Level 2)** | <br>**Total** |
| **Assets** |  |  |  |
| **Cash equivalents:** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Available-for-sale: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Government and institutional money market funds | $740730 | $— | $740730 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Corporate obligations (1) |  | 397707 | 397707 |
| **Short-term investments (2):** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Available-for-sale: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Corporate obligations (1) |  | 656839 | 656839 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Bank obligations (1) |  | 496076 | 496076 |
| **Other assets:** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Forward foreign currency exchange contracts (3) |  | 6708 | 6708 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred compensation plan investments | 105188 |  | 105188 |
| **Total assets measured at fair value** | $845918 | $1557330 | $2403248 |
| **Liabilities** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Forward foreign currency exchange contracts (3) | $— | $7975 | $7975 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest rate derivatives (4) |  | 12550 | 12550 |
| **Total liabilities measured at fair value** | $— | $20525 | $20525 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)The amortized cost of the Company's investments classified as available-for-sale as of November 1, 2025 was $1.6 billion.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)Available-for-sale securities are classified as current assets on the Condensed Consolidated Balance Sheets if the securities are available to be converted into cash to fund current operations.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)The Company has master netting arrangements by counterparty with respect to derivative contracts. See Note 8, *Derivatives,* in these Notes to Condensed Consolidated Financial Statements for more information related to the Company's master netting arrangements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4)The carrying value of the related debt was adjusted by an equal and offsetting amount. The fair value of interest rate derivatives is estimated using a discounted cash flow analysis based on the contractual terms of the derivatives. See Note 8, *Derivatives,* in these Notes to Condensed Consolidated Financial Statements.

***Assets and Liabilities Not Recorded at Fair Value on a Recurring Basis***

***San Jose, California leased property asset group —*** As a result of a sublease transaction involving a leased property

in San Jose, California, the Company estimated the fair value of the sublease assets using discounted cash flows from the estimated net sublease rental income discounted at a market rate and recorded an impairment charge which represented the excess carrying value of the asset group associated with the leased property over its estimated fair value. These assets are considered a Level 2 fair value measurement. See Note 5, *Special Charges, Net*, in these Notes to Condensed Consolidated Financial Statements for additional information.

***Debt —*** The table below presents the estimated fair values of certain financial instruments not recorded at fair value on a recurring basis. Given the short tenure of the Company's commercial paper notes, the carrying value of the outstanding commercial paper notes approximates the fair values, and therefore, are excluded from the table below ($550.2 million and $446.6 million as of May 2, 2026 and November 1, 2025, respectively). The fair values of the senior unsecured notes are obtained from broker prices and are classified as Level 1 measurements according to the fair value hierarchy.

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **May 2, 2026** | **May 2, 2026** | **November 1, 2025** | **November 1, 2025** |
| | **Principal Amount Outstanding** | **Fair Value** | **Principal Amount Outstanding** | **Fair Value** |
| 2026 Notes, due December 2026 | 900000 | 897767 | 900000 | 895623 |
| 2027 Notes, due June 2027 | 440212 | 437241 | 440212 | 436916 |
| 2028 Notes, due June 2028 | 850000 | 850341 | 850000 | 856345 |
| 2028 Notes, due October 2028 | 750000 | 707652 | 750000 | 704186 |
| 2030 Notes, due June 2030 | 650000 | 652444 | 650000 | 659834 |
| 2031 Notes, due October 2031 | 1000000 | 884422 | 1000000 | 884390 |
| 2032 Notes, due October 2032 | 300000 | 298028 | 300000 | 301546 |
| 2034 Notes, due April 2034 | 550000 | 561447 | 550000 | 571370 |
| 2036 Notes, due December 2036 | 144278 | 137425 | 144278 | 138756 |
| 2041 Notes, due October 2041 | 750000 | 546296 | 750000 | 555925 |
| 2045 Notes, due December 2045 | 332587 | 321506 | 332587 | 327992 |
| 2051 Notes, due October 2051 | 1000000 | 641436 | 1000000 | 662609 |
| 2054 Notes, due April 2054 | 550000 | 524949 | 550000 | 541087 |
| Total senior unsecured notes | $8217077 | $7460954 | $8217077 | $7536579 |

---

**Note 8 – Derivatives**

*Foreign Exchange Exposure Management* — The total notional amounts of forward foreign currency derivative instruments designated as hedging instruments of cash flow hedges as of May 2, 2026 and November 1, 2025 were $343.2 million and $297.0 million, respectively, and the fair values of these instruments in the Company's Condensed Consolidated Balance Sheets were as follows:

---

| | | | |
|:---|:---|:---|:---|
| | | **Fair Value At** | **Fair Value At** |
| |<br>**Balance Sheet Location** | **May 2, 2026** | **November 1, 2025** |
| Forward foreign currency exchange contracts | Prepaid expenses and other current assets | $1162 | $4403 |
| Forward foreign currency exchange contracts | Accrued liabilities | $6150 | $4399 |

---

As of May 2, 2026 and November 1, 2025, the total notional amounts of undesignated hedges related to forward foreign currency exchange contracts were $319.0 million and $207.3 million, respectively, and the fair values of undesignated hedges in the Company's Condensed Consolidated Balance Sheets were as follows:

---

| | | | |
|:---|:---|:---|:---|
| | | **Fair Value At** | **Fair Value At** |
| |<br>**Balance Sheet Location** | **May 2, 2026** | **November 1, 2025** |
| Undesignated hedges related to forward foreign currency exchange contracts | Prepaid expenses and other current assets | $5338 | $2305 |
| Undesignated hedges related to forward foreign currency exchange contracts | Accrued liabilities | $3870 | $3576 |

---

*Interest Rate Exposure Management* — The Company does not consider the risk of counterparty default to be significant. The gain or loss on the Company's interest rate swap transactions attributable to the hedged benchmark interest rate risk and the offsetting gain or loss on the related interest rate swaps were recorded as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **May 2, 2026** | **May 2, 2026** | **November 1, 2025** | **November 1, 2025** |
| **Balance Sheet Location** | **Loss on Swaps** | **Gain on Note** | **Loss on Swaps** | **Gain on Note** |
| Accrued liabilities | $23882 | $— | $12550 | $— |
| Long-term debt | $— | $23882 | $— | $12550 |

---

For further information on the unrealized holding gains (losses) on derivatives included in and reclassified out of AOCI into the Condensed Consolidated Statements of Income related to forward foreign currency exchange contracts, see Note 3, *Accumulated Other Comprehensive (Loss) Income,* in these Notes to Condensed Consolidated Financial Statements.

------

**Note 9 – Inventories**

Inventories at May 2, 2026 and November 1, 2025 were as follows:

---

| | | |
|:---|:---|:---|
| | **May 2, 2026** | **November 1, 2025** |
| Raw materials | $68165 | $70183 |
| Work in process | 1389341 | 1218625 |
| Finished goods | 390899 | 367515 |
| &nbsp;&nbsp;&nbsp;Total inventories | $1848405 | $1656323 |

---

**Note 10 – Income Taxes**

The Company's effective tax rates for the three- and six-month periods ended May 2, 2026 and May 3, 2025 were below the U.S. statutory tax rate of 21%, due to lower statutory tax rates applicable to the Company's operations in the foreign jurisdictions in which it earns income.

During fiscal 2025, the Company received an assessment from the U.S. Internal Revenue Service (IRS) for fiscal 2018 and fiscal 2019, totaling approximately $267.0 million. The assessment excludes any penalties and interest. The assessment pertains to transfer pricing arrangements between the Company and one of its wholly-owned foreign subsidiaries. The Company firmly disagrees with this assessment and maintains that its transfer pricing is appropriate. Consequently, the Company has not recorded any additional tax liability related to fiscal 2018 and fiscal 2019 in relation to this issue, nor to any other periods. The Company intends to vigorously defend its original tax return position and is currently preparing for an appeal with the IRS. Should the IRS ultimately prevail regarding its assessments for fiscal 2018 and fiscal 2019, such a resolution, along with any potential impact on subsequent fiscal years, could have a material adverse effect on the Company's income tax expense and net earnings in future periods.

**Note 11 – New Accounting Pronouncements**

*Standards Implemented*

*Income Taxes*

In December 2023, the FASB issued ASU 2023-09, *Income Taxes (Topic 740): Improvements to Income Tax Disclosures*. ASU 2023-09 requires the disaggregation of information in existing income tax disclosures related to the effective tax rate reconciliation and income taxes paid. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The Company adopted this ASU in fiscal 2026 and will include required financial statement disclosures in its Annual Report on Form 10-K for fiscal 2026.

*Standards to Be Implemented*

*Disaggregation of Income Statement Expenses*

In November 2024, the FASB issued ASU 2024-03, *Disaggregation of Income Statement Expenses*, requiring public companies to disaggregate key expense categories such as inventory purchases, employee compensation and depreciation in their financial statements. This aims to improve investor insights into company performance. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the impact adoption will have on its financial statement disclosures.

**Note 12 – Subsequent Events**

On May 19, 2026, the Board of Directors of the Company declared a cash dividend of $1.10 per outstanding share of common stock. The dividend will be paid on June 16, 2026 to all shareholders of record at the close of business on June 2, 2026 and is expected to total approximately $535.8 million.

------

---

| | |
|:---|:---|
| **ITEM 2.** | **Management's Discussion and Analysis of Financial Condition and Results of Operations** |

---

This information should be read in conjunction with the unaudited condensed consolidated financial statements and related notes included in Part I, Item 1 of this Quarterly Report on Form 10-Q and the audited consolidated financial statements and related notes and Management's Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the fiscal year ended November 1, 2025 (fiscal 2025).

This Quarterly Report on Form 10-Q, including the following discussion, contains forward-looking statements regarding future events and our future results that are subject to the safe harbor created under the Private Securities Litigation Reform Act of 1995 and other safe harbors under the Securities Act of 1933 and the Securities Exchange Act of 1934. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. These statements are based on current expectations, estimates, forecasts and projections about the industries in which we operate and the beliefs and assumptions of our management. Words such as "expects," "anticipates," "targets," "goals," "projects," "intends," "plans," "believes," "seeks," "estimates," "continues," "potential," "may," "could" and "will," and variations of such words and similar expressions are intended to identify such forward-looking statements, however, the absence of the foregoing words or expressions does not mean that a statement is not forward-looking. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors.

The following important factors and uncertainties, among others, could cause actual results to differ materially from those described in the forward-looking statements: economic, political, legal and regulatory uncertainty or conflicts; recently announced and future tariffs and other trade restrictions; changes in export classifications, import and export regulations or duties and tariffs; changes in demand for semiconductor products; performance of independent distributors; manufacturing delays, product and raw materials availability and supply chain disruptions; products may be diverted from our authorized distribution channels; our development of technologies and research and development investments; our ability to compete successfully in the markets in which we operate; our future liquidity, capital needs and capital expenditures; our ability to recruit and retain key personnel; risks related to acquisitions or other strategic transactions; unanticipated difficulties or expenditures relating to integrating acquired businesses; security breaches or other cyber incidents; risks related to the use of artificial intelligence in our business operations, products and services; adverse results in litigation; the outcome of any regulatory actions, including governmental inquiries, investigations or enforcement proceedings in the event of noncompliance or alleged noncompliance with laws or regulations; reputational damage; changes in our estimates of our expected tax rates based on current tax law; risks related to our indebtedness; the discretion of our Board of Directors to declare dividends and our ability to pay dividends in the future; factors impacting our ability to repurchase shares; and uncertainty as to the long-term value of our common stock. Additional factors that could cause actual results to differ materially from those described in these forward-looking statements include the risk factors included in Part I, Item 1A, "Risk Factors" of our Annual Report on Form 10-K for fiscal 2025. Forward-looking statements represent management's current expectations and are inherently uncertain. We undertake no obligation to revise or update any forward-looking statements, including to reflect events or circumstances occurring after the date of the filing of this report, except to the extent required by law.

------

**Results of Operations**

*Overview*

Amounts in the tables below are reflected in thousands except per share amounts and percentages.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** |
| | **May 2, 2026** | **May 3, 2025** | **$ Change** | **% Change** |
| Revenue | $3623465 | $2640068 | $983397 | 37% |
| Gross margin % | 67.3% | 61.0% |  |  |
| Net income | $1176350 | $569770 | $606580 | 106% |
| Net income as a % of revenue | 32.5% | 21.6% |  |  |
| Diluted EPS | $2.40 | $1.14 | $1.26 | 111% |
|  | **Six Months Ended** | **Six Months Ended** | **Six Months Ended** | **Six Months Ended** |
|  | **May 2, 2026** | **May 3, 2025** | **$ Change** | **% Change** |
| Revenue | $6783728 | $5063242 | $1720486 | 34% |
| Gross margin % | 66.1% | 60.1% |  |  |
| Net income | $2007176 | $961086 | $1046090 | 109% |
| Net income as a % of revenue | 29.6% | 19.0% |  |  |
| Diluted EPS | $4.09 | $1.93 | $2.16 | 112% |

---

*Revenue Trends by End Market*

The following tables summarize revenue by end market. The categorization of revenue by end market is determined using a variety of data points including the technical characteristics of the product, the "sold to" customer information, the "ship to" customer information and the end customer product or application into which our product will be incorporated. The assignment of products to end markets may change over time. When this occurs, we reclassify revenue by end market for prior periods. Such reclassifications typically do not materially change the sizing of, or the underlying trends of results within, each end market.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** |
| | **May 2, 2026** | **May 2, 2026** | **May 2, 2026** | **May 3, 2025** | **May 3, 2025** |
| | **Revenue** | **% of<br>Revenue\*** | **Y/Y%** | **Revenue** | **% of<br>Revenue\*** |
| Industrial | $1799413 | 50% | 56% | $1150315 | 44% |
| Automotive | 871565 | 24% | 2% | 856090 | 32% |
| Communications | 554728 | 15% | 79% | 310604 | 12% |
| Consumer | 397759 | 11% | 23% | 323059 | 12% |
| Total revenue | $3623465 | 100% | 37% | $2640068 | 100% |
|  | **Six Months Ended** | **Six Months Ended** | **Six Months Ended** | **Six Months Ended** | **Six Months Ended** |
|  | **May 2, 2026** | **May 2, 2026** | **May 2, 2026** | **May 3, 2025** | **May 3, 2025** |
|  | **Revenue** | **% of<br>Revenue\*** | **Y/Y%** | **Revenue** | **% of<br>Revenue\*** |
| Industrial | $3296449 | 49% | 48% | $2220569 | 44% |
| Automotive | 1681709 | 25% | 5% | 1596349 | 32% |
| Communications | 1009911 | 15% | 65% | 610905 | 12% |
| Consumer | 795659 | 12% | 25% | 635419 | 13% |
| Total revenue | $6783728 | 100% | 34% | $5063242 | 100% |
| \* The sum of the individual percentages may not equal the total due to rounding. | \* The sum of the individual percentages may not equal the total due to rounding. | \* The sum of the individual percentages may not equal the total due to rounding. | \* The sum of the individual percentages may not equal the total due to rounding. | \* The sum of the individual percentages may not equal the total due to rounding. | \* The sum of the individual percentages may not equal the total due to rounding. |

---

Revenue increased 37% and 34% in the three- and six-month periods ended May 2, 2026 as compared to the same periods of the prior fiscal year as a result of a broad-based increase in demand for our products, notably within all Industrial

------

sub-markets with the highest growth coming from our test equipment and aerospace and defense sub-markets. Revenue also increased in the data center portion of the Communications end market related to artificial intelligence-driven infrastructure investments.

*Revenue by Sales Channel*

The following tables summarize revenue by sales channel. We sell our products globally through a direct sales force, third-party distributors, independent sales representatives and via our website. Distributors are customers that buy products with the intention of reselling them. Direct customers are non-distributor customers and consist primarily of original equipment manufacturers. Other customers include the U.S. government, government prime contractors and certain commercial customers for which revenue is recorded over time.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** |
| | **May 2, 2026** | **May 2, 2026** | **May 3, 2025** | **May 3, 2025** |
| | **Revenue** | **% of Revenue\*** | **Revenue** | **% of Revenue\*** |
| Channel |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Distributors | $2071312 | 57% | $1480088 | 56% |
| &nbsp;&nbsp;&nbsp;&nbsp;Direct customers | 1520090 | 42% | 1125775 | 43% |
| &nbsp;&nbsp;&nbsp;&nbsp;Other | 32063 | 1% | 34205 | 1% |
| Total revenue | $3623465 | 100% | $2640068 | 100% |
|  | **Six Months Ended** | **Six Months Ended** | **Six Months Ended** | **Six Months Ended** |
|  | **May 2, 2026** | **May 2, 2026** | **May 3, 2025** | **May 3, 2025** |
|  | **Revenue** | **% of Revenue\*** | **Revenue** | **% of Revenue\*** |
| Channel |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Distributors | $3813606 | 56% | $2855552 | 56% |
| &nbsp;&nbsp;&nbsp;&nbsp;Direct customers | 2897220 | 43% | 2145647 | 42% |
| &nbsp;&nbsp;&nbsp;&nbsp;Other | 72902 | 1% | 62043 | 1% |
| Total revenue | $6783728 | 100% | $5063242 | 100% |
| \* The sum of the individual percentages may not equal the total due to rounding. | \* The sum of the individual percentages may not equal the total due to rounding. | \* The sum of the individual percentages may not equal the total due to rounding. | \* The sum of the individual percentages may not equal the total due to rounding. | \* The sum of the individual percentages may not equal the total due to rounding. |

---

As indicated in the tables above, the percentage of total revenue sold via each channel has remained relatively consistent in the periods presented, but can fluctuate from time to time based on end market revenue trends.

*Gross Margin*

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** | **Six Months Ended** | **Six Months Ended** |
| | **May 2, 2026** | **May 3, 2025** | **$ Change** | **% Change** | **May 2, 2026** | **May 3, 2025** | **$ Change** | **% Change** |
| Gross margin | $2439798 | $1611610 | $828188 | 51% | $4484773 | $3041913 | $1442860 | 47% |
| Gross margin % | 67.3% | 61.0% |  |  | 66.1% | 60.1% |  |  |

---

Gross margin percentage increased by 630 and 600 basis points in the three- and six-month periods ended May 2, 2026 as compared to the same periods of the prior fiscal year, primarily due to higher utilization of our manufacturing fixed costs as a result of increased customer demand and favorable mix of products sold into our end markets.

*Research and Development (R&D)*

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** | **Six Months Ended** | **Six Months Ended** |
| | **May 2, 2026** | **May 3, 2025** | **$ Change** | **% Change** | **May 2, 2026** | **May 3, 2025** | **$ Change** | **% Change** |
| R&D expenses | $509323 | $441837 | $67486 | 15% | $976723 | $844729 | $131994 | 16% |
| R&D expenses as a % of revenue | 14% | 17% |  |  | 14% | 17% |  |  |

---

------

R&D expenses increased in the three- and six-month periods ended May 2, 2026, as compared to the same periods of the prior fiscal year, primarily as a result of higher R&D employee-related variable compensation expenses. R&D expenses declined as a percentage of revenue, primarily reflecting higher revenue levels and improved operating leverage. We expect to continue the development of innovative technologies and processes for new products, which we view as critical to our future growth. We believe that a continued commitment to R&D is essential to maintain product leadership with our existing products as well as to provide innovative new product offerings.

*Selling, Marketing, General and Administrative (SMG&A)*

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** | **Six Months Ended** | **Six Months Ended** |
| | **May 2, 2026** | **May 3, 2025** | **$ Change** | **% Change** | **May 2, 2026** | **May 3, 2025** | **$ Change** | **% Change** |
| SMG&A expenses | $362810 | $302669 | $60141 | 20% | $708063 | $587465 | $120598 | 21% |
| SMG&A expenses as a % of revenue | 10% | 11% |  |  | 10% | 12% |  |  |

---

SMG&A expenses increased in the three- and six-month periods ended May 2, 2026, as compared to the same periods of the prior fiscal year, primarily as a result of higher SMG&A employee-related variable compensation expenses and higher salary and benefit expenses. SMG&A expenses declined as a percentage of revenue, primarily reflecting higher revenue levels and improved operating leverage.

*Special Charges, Net*

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** | **Six Months Ended** | **Six Months Ended** |
| | **May 2, 2026** | **May 3, 2025** | **$ Change** | **% Change** | **May 2, 2026** | **May 3, 2025** | **$ Change** | **% Change** |
| Special charges, net | $— | $1745 | $(1745) | (100)% | $47982 | $65632 | $(17650) | (27)% |

---

Special charges, net decreased in the three- and six-month periods ended May 2, 2026, as compared to the same periods of the prior fiscal year, primarily due to decreased charges related to our Global Repositioning Actions. The decrease in the six-month period was partially offset by a $15.6 million impairment charge recorded in the first quarter of fiscal 2026 related to the asset group in our leased facilities in San Jose, California.

*Provision for Income Taxes*

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** | **Six Months Ended** |
| | **May 2, 2026** | **May 3, 2025** | **$ Change** | **May 2, 2026** | **May 3, 2025** | **$ Change** |
| Provision for income taxes | $148478 | $56158 | $92320 | $263523 | $100418 | $163105 |
| Effective income tax rate | 11.2% | 9.0% |  | 11.6% | 9.5% |  |

---

The primary driver for our increased tax rate in the three- and six-month periods ended May 2, 2026, as compared to the same periods of the prior fiscal year, is the increase in taxes paid on our international profits. This results in higher non-deductible foreign tax expense under the global intangible low-taxed income (GILTI) regime, which has the effect of increasing our effective tax rate.

*Net Income*

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** | **Six Months Ended** | **Six Months Ended** |
| | **May 2, 2026** | **May 3, 2025** | **$ Change** | **% Change** | **May 2, 2026** | **May 3, 2025** | **$ Change** | **% Change** |
| Net income | $1176350 | $569770 | $606580 | 106% | $2007176 | $961086 | $1046090 | 109% |
| Net income as a % of revenue | 32.5% | 21.6% |  |  | 29.6% | 19.0% |  |  |
| Diluted EPS | $2.40 | $1.14 |  |  | $4.09 | $1.93 |  |  |

---

Net income increased in the three-month period ended May 2, 2026, as compared to the same period of the prior fiscal year, as the result of a $701.7 million increase in operating income, partially offset by a $92.3 million increase in provision for income taxes.

------

Net income increased in the six-month period ended May 2, 2026, as compared to the same period of the prior fiscal year, as the result of a $1,207.4 million increase in operating income, partially offset by a $163.1 million increase in provision for income taxes.

**Liquidity and Capital Resources**

At May 2, 2026, our principal source of liquidity was $3.4 billion of cash, cash equivalents and short-term investments, of which approximately $2.2 billion was held in the United States, and the balance of which was held outside the United States in various foreign subsidiaries. We manage our worldwide cash requirements by, among other things, reviewing available funds held by our foreign subsidiaries and the cost effectiveness by which those funds can be accessed in the United States. We do not expect current regulatory restrictions or taxes on repatriation to have a material adverse effect on our overall liquidity, financial condition or results of operations. Our cash, cash equivalents and short-term investments consist of highly liquid investments, including money market funds and corporate and bank obligations. We maintain these balances with counterparties with high credit ratings, and continually monitor the amount of credit exposure to any one issuer and diversify our investments in order to minimize our credit risk.

We believe that our existing sources of liquidity and cash expected to be generated from future operations, together with existing and anticipated available short- and long-term financing, will be sufficient to fund operations, capital expenditures, acquisitions, research and development efforts and dividend payments in the immediate future and for at least the next twelve months.

---

| | | |
|:---|:---|:---|
| | **Six Months Ended** | **Six Months Ended** |
| | **May 2, 2026** | **May 3, 2025** |
| Net cash provided by operating activities | $2240556 | $1946287 |
| Net cash provided by operations as a % of revenue | 33% | 38% |
| Net cash (used for) provided by investing activities | $(158955) | $133892 |
| Net cash used for financing activities | $(2144091) | $(1695286) |

---

The following changes contributed to the net change in cash and cash equivalents in the six-month period ended May 2, 2026 as compared to the same period in fiscal 2025.

*Operating Activities*

Cash provided by operating activities is net income adjusted for certain non-cash items and changes in operating assets and liabilities. The increase in cash provided by operating activities during the six-month period ended May 2, 2026, as compared to the same period of the prior fiscal year, was mainly the result of higher net income adjusted for non-cash items.

*Investing Activities*

Investing cash flows generally consist of purchases and sales of property, plant and equipment, purchases, sales and maturities of available-for-sale investments; and acquisitions of other businesses. The change in investing cash flows during the six-month period ended May 2, 2026, as compared to the same period of the prior fiscal year, was primarily the result of a decrease in maturities of our available-for-sale investments. The change in investing cash flows also included the sale of property, plant and equipment during fiscal 2025.

*Financing Activities* 

Financing cash flows generally consist of payments of dividends to stockholders, repurchases of common stock, issuances and repayments of debt and proceeds from the sale of shares of common stock pursuant to employee equity incentive plans. The change in cash used for financing activities during the six-month period ended May 2, 2026, as compared to the same

------

period of the prior fiscal year, was primarily the result of higher common stock repurchases partially offset by debt repayments during fiscal 2025.

*Working Capital*

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **May 2, 2026** | **November 1, 2025** | **$ Change** | **% Change** |
| Accounts receivable | $2051733 | $1436075 | $615658 | 43% |
| Days sales outstanding\* | 43 | 44 |  |  |
| Inventory | $1848405 | $1656323 | $192082 | 12% |
| Days cost of sales in inventory\* | 139 | 130 |  |  |

---

_______________________________________

\*We use the average of the current quarter and prior quarter ending net accounts receivable and ending inventory balance in our calculation of days sales outstanding and days cost of sales in inventory, respectively.

The increase in accounts receivable in dollars was primarily the result of increased sales levels and variations in the timing of collections and billings.

Inventory increased primarily as a result of building inventory levels to support increased demand.

Current liabilities increased to $4.5 billion at May 2, 2026 as compared to $3.2 billion at the end of fiscal 2025 primarily due to the reclassification of $0.9 billion of debt due in December 2026 to current liabilities as well as an increase in accrued liabilities, partially offset by a decrease in income taxes payable.

*Debt*

As of May 2, 2026, our debt obligations consisted of the following:

---

| | |
|:---|:---|
| | **Principal Amount Outstanding** |
| Commercial paper notes | $550198 |
| 2026 Notes, due December 2026 | 900000 |
| 2027 Notes, due June 2027 | 440212 |
| 2028 Notes, due June 2028 | 850000 |
| 2028 Notes, due October 2028 | 750000 |
| 2030 Notes, due June 2030 | 650000 |
| 2031 Notes, due October 2031 | 1000000 |
| 2032 Notes, due October 2032 | 300000 |
| 2034 Notes, due April 2034 | 550000 |
| 2036 Notes, due December 2036 | 144278 |
| 2041 Notes, due October 2041 | 750000 |
| 2045 Notes, due December 2045 | 332587 |
| 2051 Notes, due October 2051 | 1000000 |
| 2054 Notes, due April 2054 | 550000 |
| Total debt | $8767275 |

---

The indentures governing our outstanding notes contain covenants that may limit our ability to: incur, create, assume or guarantee any debt for borrowed money secured by a lien upon a principal property; enter into sale and lease-back transactions with respect to a principal property; and consolidate with or merge into, or transfer or lease all or substantially all of our assets to, any other party. As of May 2, 2026, we were in compliance with these covenants.

Under our commercial paper program, we may issue short-term, unsecured commercial paper notes in amounts up to a maximum aggregate face amount of $3.0 billion outstanding at any time, with maturities of up to 397 days from the date of issuance. As of May 2, 2026, we had $0.6 billion of outstanding borrowings under the commercial paper program recorded in the Condensed Consolidated Balance Sheet. We intend to use the net proceeds of the commercial paper program for general corporate purposes, including without limitation, repayment of indebtedness, stock repurchases, acquisitions, capital expenditures and working capital.

------

*Revolving Credit Facility*

Our Fourth Amended and Restated Revolving Credit Agreement, dated as of April 11, 2025, with Bank of America N.A. as administrative agent and the other banks identified therein as lenders (the Revolving Credit Agreement) provides for a five-year unsecured revolving credit facility in an aggregate principal amount not to exceed $3.0 billion (subject to certain terms and conditions).

We may borrow under the Revolving Credit Agreement in the future and use the proceeds for repayment of existing indebtedness, stock repurchases, acquisitions, capital expenditures, working capital and other lawful corporate purposes. The terms of the Revolving Credit Agreement impose restrictions on our ability to undertake certain transactions, to create certain liens on assets and to incur certain subsidiary indebtedness. In addition, the Revolving Credit Agreement contains an interest coverage covenant which requires the ratio of consolidated earnings before interest, taxes, depreciation and amortization (EBITDA) to consolidated interest charges to be greater than 3.0 to 1.0. As of May 2, 2026, we were in compliance with these covenants.

*Stock Repurchase Program*

As of May 2, 2026, our Board of Directors had authorized us to repurchase an aggregate of $26.7 billion of our common stock under our common stock repurchase program and $8.5 billion remained available for repurchases under the current authorized program. Repurchased shares are held as authorized but unissued shares of common stock. Unless terminated earlier by resolution of our Board of Directors, the repurchase program will expire when the full dollar amount of the authorization has been used to repurchase shares under the program. Future repurchases of common stock will be dependent upon our financial position, results of operations, outlook, liquidity and other factors we deem relevant.

*Capital Expenditures*

Net additions to property, plant and equipment were $247.0 million in the first six months of fiscal 2026. We expect capital expenditures for fiscal 2026 to be between approximately 4% and 6% of fiscal 2026 revenue. These capital expenditures will be funded with a combination of cash on hand and cash expected to be generated from future operations, together with existing and anticipated available short- and long-term financing.

*Dividends*

On May 19, 2026, our Board of Directors declared a cash dividend of $1.10 per outstanding share of common stock. The dividend will be paid on June 16, 2026 to all shareholders of record at the close of business on June 2, 2026 and is expected to total approximately $535.8 million. We currently expect quarterly dividends to continue in future periods, although they remain subject to determination and declaration by our Board of Directors. The payment of future dividends, if any, will be based on several factors, including our financial performance, outlook and liquidity.

**New Accounting Pronouncements**

From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board that are adopted by us as of the specified effective date. Unless otherwise discussed, management believes that the impact of recently issued standards will not have a material impact on our future financial condition, results of operations, and disclosures. See Note 11, *New Accounting Pronouncements,* in the Notes to Condensed Consolidated Financial Statements in Part I, Item 1 of this Quarterly Report on Form 10-Q for a description of recently issued and adopted accounting pronouncements, including the dates of adoption and impact on our historical financial condition, results of operations, and disclosures.

------

---

| | |
|:---|:---|
| **ITEM 3.** | **Quantitative and Qualitative Disclosures About Market Risk** |

---

We are subject to market risks related to our financial instruments, including those identified in Part II, Item 7A, "Quantitative and Qualitative Disclosures about Market Risk" of our Annual Report on Form 10-K for the fiscal year ended November 1, 2025, which was filed with the Securities and Exchange Commission on November 25, 2025. There were no material changes in the six-month period ended May 2, 2026 to the information identified in the Annual Report on Form 10-K for the fiscal year ended November 1, 2025.

---

| | |
|:---|:---|
| **ITEM 4.** | **Controls and Procedures** |

---

(a) *Evaluation of Disclosure Controls and Procedures*. Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of May 2, 2026. The term "disclosure controls and procedures," as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (Exchange Act), means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission's rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company's management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on the evaluation of our disclosure controls and procedures as of May 2, 2026, our Chief Executive Officer and Chief Financial Officer concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable assurance level.

(b) *Changes in Internal Control over Financial Reporting.* No change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) occurred during the quarter ended May 2, 2026 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

------

**PART II — OTHER INFORMATION**

---

| | |
|:---|:---|
| **ITEM 1A.** | **Risk Factors** |

---

We are subject to a number of risks that could adversely affect our business, results of operations, financial condition and future prospects, including those identified in Part I, Item 1A, "Risk Factors" of our Annual Report on Form 10-K for the fiscal year ended November 1, 2025, which was filed with the Securities and Exchange Commission on November 25, 2025.

---

| | |
|:---|:---|
| **ITEM 2.** | **Unregistered Sales of Equity Securities and Use of Proceeds** |

---

**Issuer Purchases of Equity Securities** 

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Period** | **Total Number of<br>Shares Purchased<br>(a)** | **Average Price<br>Paid Per Share (b)** | **Total Number of<br>Shares Purchased as<br>Part of Publicly<br>Announced Plans or<br>Programs (c)** | **Approximate Dollar<br>Value of Shares that<br>May Yet Be<br>Purchased Under<br>the Plans or<br>Programs** |
| February 1, 2026 through February 28, 2026 | 409019 | $335.78 | 402020 | $9013190935 |
| March 1, 2026 through March 28, 2026 | 1145447 | $316.71 | 836539 | $8746470019 |
| March 29, 2026 through May 2, 2026 | 765022 | $353.14 | 699581 | $8496437073 |
| Total | 2319488 | $332.09 | 1938140 | $8496437073 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)Includes an aggregate of 381,348 shares withheld by us from employees to satisfy employee tax obligations upon vesting of restricted stock units/awards granted to our employees under our equity compensation plans.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)The average price paid for shares in connection with vesting of restricted stock units/awards are averages of the closing stock price at the vesting date which is used to calculate the number of shares to be withheld.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)Shares repurchased pursuant to the stock repurchase program publicly announced on August 12, 2004 and updated thereafter. Under the repurchase program, we may repurchase outstanding shares of our common stock from time to time in the open market and through privately negotiated transactions.

---

| | |
|:---|:---|
| **ITEM 5.** | **Other Information** |

---

The following table describes contracts, instructions or written plans for the sale or purchase of our securities adopted or terminated by our directors or officers during the second quarter of fiscal 2026 that are intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act (Rule 10b5-1 trading arrangement).

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Name and Title** | **Action** | **Date of Adoption/<br>Termination** | **Duration of Rule 10b5-1 Trading Arrangement** | **Aggregate Number of Securities to Be Purchased or Sold** |
| Ray Stata, Director | Adoption | March 6, 2026 | Until May 6, 2027, or such earlier date upon which all transactions are completed or expire without execution | Sale of up to <br>34,000 shares |
| Karen Golz, Director | Adoption | March 12, 2026 | Until March 3, 2027, or such earlier date upon which all transactions are completed or expire without execution | Sale of up to <br>3,000 shares |

---

None of our officers or directors adopted or terminated a non-Rule 10b5-1 trading arrangement (as defined in Item 408(c) of Regulation S-K) during the second quarter of fiscal 2026.

------

---

| | |
|:---|:---|
| **ITEM 6.** | **Exhibits** |

---

---

| | |
|:---|:---|
| **<u>Exhibit No.</u>** | **Description** |
| 10.1 | <u>[Amended and Restated Analog Devices, Inc. 2020 Equity Incentive Plan](https://www.sec.gov/Archives/edgar/data/0000006281/000000628126000022/amendedandrestated2020equi.htm)</u>, filed as Exhibit 10.1 to the Company's Current Report on Form 8-K as filed with the Commission on March 12, 2026. |
| 31.1† | <u>[Certification Pursuant to Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (Chief Executive Officer).](a2q26exhibit311.htm)</u> |
| 31.2† | <u>[Certification Pursuant to Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (Chief Financial Officer).](a2q26exhibit312.htm)</u> |
| 32.1\* | <u>[Certification Pursuant to 18 U.S.C. Section 1350 (Chief Executive Officer).](a2q26exhibit321.htm)</u> |
| 32.2\* | <u>[Certification Pursuant to 18 U.S.C. Section 1350 (Chief Financial Officer).](a2q26exhibit322.htm)</u> |
| 101.INS† | XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the inline XBRL document. |
| 101.SCH† | Inline XBRL Schema Document. |
| 101.CAL† | Inline XBRL Calculation Linkbase Document. |
| 101.LAB† | Inline XBRL Labels Linkbase Document. |
| 101.PRE† | Inline XBRL Presentation Linkbase Document. |
| 101.DEF† | Inline XBRL Definition Linkbase Document. |
| 104† | Cover page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension information contained in Exhibits 101). |
| † | Filed herewith.  |
| \* | Furnished herewith. |

---

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | | |
|:---|:---|:---|
| | ANALOG DEVICES, INC. | ANALOG DEVICES, INC. |
| Date: May 20, 2026 | By: | /s/ Vincent Roche |
|  |  | Vincent Roche |
|  |  | Chief Executive Officer and Chair of the Board of Directors |
|  |  | (Principal Executive Officer) |
| Date: May 20, 2026 | By: | /s/ Richard C. Puccio, Jr. |
|  |  | Richard C. Puccio, Jr.  |
|  |  | Executive Vice President and Chief Financial Officer |
|  |  | (Principal Financial Officer) |

---

## Exhibit 31.1

**Exhibit 31.1**

**CERTIFICATION**

I, Vincent Roche, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.I have reviewed this quarterly report on Form 10-Q of Analog Devices, Inc.;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | |
|:---|:---|
| | /s/ Vincent Roche |
| | Vincent Roche |
| | Chief Executive Officer and Chair of the Board of  |
| | Directors |
| | (Principal Executive Officer) |
| Date: May 20, 2026 | |

---

## Exhibit 31.2

**Exhibit 31.2**

**CERTIFICATION**

I, Richard C. Puccio, Jr., certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.I have reviewed this quarterly report on Form 10-Q of Analog Devices, Inc.;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | |
|:---|:---|
| | /s/ Richard C. Puccio, Jr. |
| | Richard C. Puccio, Jr. |
| | Executive Vice President and Chief Financial Officer |
| | (Principal Financial Officer) |
| Date: May 20, 2026 | |

---

## Exhibit 32.1

**Exhibit 32.1**

**Certification Pursuant to 18 U.S.C. Section 1350, As Adopted Pursuant to**

**Section 906 of the Sarbanes-Oxley Act of 2002**

In connection with the Quarterly Report on Form 10-Q of Analog Devices, Inc. (the "Company") for the period ended May 2, 2026 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned, Vincent Roche, Chief Executive Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | |
|:---|:---|
| | /s/ Vincent Roche |
| | Vincent Roche |
| | Chief Executive Officer |
| Date: May 20, 2026 | |

---

## Exhibit 32.2

**Exhibit 32.2**

**Certification Pursuant to 18 U.S.C. Section 1350, As Adopted Pursuant to**

**Section 906 of the Sarbanes-Oxley Act of 2002**

In connection with the Quarterly Report on Form 10-Q of Analog Devices, Inc. (the "Company") for the period ended May 2, 2026 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned, Richard C. Puccio, Jr., Chief Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | |
|:---|:---|
| | /s/ Richard C. Puccio, Jr. |
| | Richard C. Puccio, Jr.  |
| | Chief Financial Officer |
| Date: May 20, 2026 | |

---

<br>